Key result
STARD10 deletion reduces β-cell formation and impairs metabolism, linking its loss to T2D risk.
Why the study?
STARD10 is associated with type 2 diabetes risk and beta cell function, but its role in human beta cell development and function remains unclear.
Does STARD10 deletion impair human β cell differentiation and alter triglyceride metabolism?
Does STARD10 deletion impair human β cell differentiation and alter triglyceride metabolism?
STARD10 deletion impairs human β cell differentiation and function while increasing triglyceride levels, providing mechanistic insight into its association with type 2 diabetes risk.
STARD10 may modulate β cell development and lipid metabolism in T2D; leaves open therapeutic targeting pending human validation.
The STARD10 gene encodes for a lipid transfer protein and is associated with type 2 diabetes (T2D) risk and β cell function. However, the role of STARD10 in human β cell development and function are still unclear. Here, we deleted STARD10 in human embryonic stem cells and differentiated them into β-like cells. The deletion of STARD10 reduced the formation of INS⁺ β-like cells and proliferation. Lipidomics analyses revealed that STARD10-null β-like cells had higher triglyceride levels. Consistently, the expression levels of ETFB, which is involved in fatty acid β-oxidation, were severely reduced in STARD10-null β-like cells. STARD10-null β-like cells also had reduced glycolytic function, mitochondrial oxidative phosphorylation, and palmitate oxidation, which can likely contribute to slower proliferation and β cell dysfunction. Overall, our findings provided further insights into the role of STARD10 in human β cell development and function, and how its loss-of-function can contribute to increased T2D risk.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question. STARD10 deletion reduced human β-like cell formation and proliferation, increased triglyceride levels, and impaired metabolism, linking its loss to β cell dysfunction and T2D risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: